Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session
Liquidia Corp shares slid about 8% in afternoon trade on Friday, giving back earlier gains and underperforming the broader biotech group. The stock was down $2.79 at $31.70, after trading between $30.76 and $34.97. Volume topped 1.88 million shares. The move matters because Liquidia has become a high-volatility bet on sales of Yutrepia, its inhaled treprostinil therapy for pulmonary hypertension.…
